Stable Silk Fibroin Formulation via TRIS Buffer Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing and processing silk fibroin lack efficiency in creating stable, solubilized formulations that maintain molecular weight and prevent gel formation, which are essential for various industrial applications.

Innovation Solution

A method involving the preparation of a processed silk fibroin solution in a TRIS buffer at specific pH and temperature conditions, with controlled pressure and time, to achieve a stable, solubilized silk fibroin preparation that maintains molecular weight and remains clear, preventing gel formation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional methods are used to process silk fibroin, then production can proceed with standard procedures, but the formulations become unstable and form gels

Engineering Contradiction:
Improveformulation stabilityVSAvoidgel formation
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent applies parameter changes by optimizing pH (maintaining between 5.0-9.0 using Tris buffer), temperature (treating at 100-135°C), and pressure (0-30 psi) conditions during silk fibroin processing. These controlled parameter changes prevent unwanted gel formation while maintaining formulation stability and molecular weight integrity.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If standard processing conditions are applied, then the process is simple and quick, but molecular weight changes by more than 33%

Engineering Contradiction:
Improvemolecular weight stabilityVSAvoidprocessing time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent uses specific parameter changes including treating at elevated temperatures (100-135°C) for controlled time periods (1-90 minutes) at specific pressures (0-30 psi) to achieve both molecular weight stability (change less than 33%) and reasonable processing efficiency.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces Tris buffer as an intermediary substance to maintain pH stability during processing. This intermediary helps control the chemical environment, preventing excessive molecular weight degradation while allowing efficient processing.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Stability of the object's composition

If silk fibroin is processed without controlled conditions, then processing is faster, but the preparation becomes cloudy and unstable

Engineering Contradiction:
Improvepreparation clarity and stabilityVSAvoidprocessing control requirements
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The patent implements controlled parameter changes including maintaining pH 5.0-9.0 with Tris buffer, treating at 100-135°C, and applying 0-30 psi pressure to achieve clear, stable silk fibroin preparations. These controlled conditions prevent cloudiness and instability while maintaining practical processing complexity.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS12161693B2Methods of making stable silk fibroin formulations
Publication Date: 2024.12.10 COCOON BIOTECH INC

AI summary

The present disclosure describes methods of preparing stable, solubilized silk fibroin preparations. The methods include providing a processed silk fibroin preparation. preparing a solution of the processed silk fibroin preparation in an aqueous TRIS buffer to provide a fibroin solution, treating the fibroin solution at least at a first pressure of 0 to 30 psi and a first temperature of 100° C. to 135° C. for a first time of 1 to 90 min to provide the stable. solubilized silk fibroin preparation. The stable, solubilized silk fibroin preparation has a molecular weight that changes by less than 33% during the first and optional second treating step, does not form a gel during the first and optional second treating step, remains clear after the first and optional second treating step, or a combination thereof.